Miłosz Parczewski
- Virology top 2%
- HIV Research and Treatment 47
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment 35
- HIV/AIDS Research and Interventions 32
- COVID-19 Clinical Research Studies 25
- SARS-CoV-2 and COVID-19 Research 15
- Neurology top 5%
- Long-Term Effects of COVID-19 19
- Hepatology top 10%
- Hepatitis C virus research 12
- Parasitology top 10%
-
- HIV-related health complications and treatments 17
- Co-authors
- Anna UrbańskaAndrzej CiechanowiczMagdalena Leszczyszyn‐PynkaDorota Zarębska‐MichalukRobert FlisiakAndrzej HorbanKrzysztof TomasiewiczAnna Piekarska
- Cited by
- VirologyInfectious DiseasesNeurology
- Journals
- SHILAP Revista de lepidopterología (2 papers)PLoS ONE (5 papers)Clinical Infectious Diseases (2 papers)
- Partner nations
- PolandGermanyUnited Kingdom
In The Last Decade
Miłosz Parczewski
140 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 104
- Virology 244
- Infectious Diseases 606
- Neurology 198
- Hepatology 81
- Parasitology 54
Countries citing papers authored by Miłosz Parczewski
This map shows the geographic impact of Miłosz Parczewski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miłosz Parczewski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miłosz Parczewski more than expected).
Fields of papers citing papers by Miłosz Parczewski
This network shows the impact of papers produced by Miłosz Parczewski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miłosz Parczewski. The network helps show where Miłosz Parczewski may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Miłosz Parczewski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 4 | |
| 4 | 2025 | 2 | |
| 5 | 2025 | 0 | |
| 6 | 2025 | 0 | |
| 7 | 2025 | 1 | |
| 8 | 2025 | 3 | |
| 9 | 2025 | 2 | |
| 10 | 2024 | 1 | |
| 11 | 2024 | 2 | |
| 12 | 2024 | 2 | |
| 13 | 2024 | 1 | |
| 14 | 2023 | 15 | |
| 15 | 2022 | 3 | |
| 16 | 2022 | 6 | |
| 17 | 2021 | 17 | |
| 18 | 2016 | 10 | |
| 19 | Sickle Cell Anemia-Associated Beta-Globin Mutation in Shagia and Manasir Tribes from Sudan | 2011 | 2 |
| 20 | Osteoblast activation factors in HIV-infected patients on antiretroviral therapy | 2010 | 1 |
About Miłosz Parczewski
Miłosz Parczewski is a scholar working on Virology, Infectious Diseases and Hepatology, having authored 151 papers that have together received 1.2k indexed citations. Recurring topics across this work include HIV Research and Treatment (47 papers), HIV/AIDS drug development and treatment (35 papers), HIV/AIDS Research and Interventions (32 papers), COVID-19 Clinical Research Studies (25 papers), Long-Term Effects of COVID-19 (19 papers), HIV-related health complications and treatments (17 papers), SARS-CoV-2 and COVID-19 Research (15 papers) and Hepatitis C virus research (12 papers). The work is most often cited by research in Virology (244 citations), Infectious Diseases (606 citations) and Neurology (198 citations). Miłosz Parczewski has collaborated with scholars based in Poland, Germany and United Kingdom. Frequent co-authors include Anna Urbańska, Andrzej Ciechanowicz, Magdalena Leszczyszyn‐Pynka, Dorota Zarębska‐Michaluk, Robert Flisiak, Andrzej Horban, Krzysztof Tomasiewicz, Anna Piekarska, Jerzy Jaroszewicz and Dorota Kozielewicz. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.